Achieve Life Sciences up 38% premarket on performance of new cytisine formulation [Seeking Alpha]
Achieve Life Sciences, Inc. - Common Shares (ACHV)
Last achieve life sciences, inc. - common shares earnings: 3/13 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.achievelifesciences.com
Company Research
Source: Seeking Alpha
Nano cap Achieve Life Sciences (NASDAQ: ACHV ) is up premarket on increased volume in response to its announcement that a new formulation of smoking cessation candidate cytisine demonstrated bioequivalence in healthy volunteer smokers with or without food. The results were similar to the previous formation that showed bioequivalence in healthy non-smoking volunteers. Chairman & CEO Rick Stewart says, We believe this new cytisine formulation will allow for an extended shelf-life and will be used in the upcoming Phase 2b clinical trial as well as the Phase 3 clinical program. We are pleased with the similar results regarding this new formulation in smokers and that the higher dose of 3 mg cytisine continues to demonstrate a good safety profile with or without food. Cytisine is a plant-based alkaloid with a strong affinity to the nicotinic acetylcholine receptor. Previously: Achieve Life Sciences up 19% premarket on cytisine development plan (July 11) See all sto
Show less
Read more
Impact Snapshot
Event Time:
ACHV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACHV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACHV alerts
High impacting Achieve Life Sciences, Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
ACHV
News
- Achieve Life Sciences, Inc. (NASDAQ: ACHV) is now covered by analysts at Jonestrading. They set a "buy" rating and a $20.00 price target on the stock.MarketBeat
- Smoking Cessation and Nicotine Deaddiction Landscape Report 2024: Therapeutic Assessment of Novel Drug Candidates, Emerging Drugs and the Route to Commercialization [Yahoo! Finance]Yahoo! Finance
- Nicotine Addiction Drug Pipeline Report 2024: Comprehensive Insights on 15+ Companies and 15+ Pipeline Drugs [Yahoo! Finance]Yahoo! Finance
- Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 ConferenceGlobeNewswire
- Achieve Life Sciences: An Excellent Drug Addressing A Large Market Could Drive 5x Returns [Seeking Alpha]Seeking Alpha
ACHV
Earnings
- 3/28/24 - Beat
ACHV
Sec Filings
- 3/28/24 - Form S-8
- 3/28/24 - Form 10-K
- 3/28/24 - Form 8-K
- ACHV's page on the SEC website